Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients — Stella

Recruiting

Back to CD30+ Peripheral T-cell Lymphoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu

Key details

Sponsor

The First Affiliated Hospital of Soochow University

Enrollment target

~47 participants

Started

November 2024

Primary completion

August 2028

Age range

18 Years – 75 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov